Publications

Sort by: Date | Author | Title

Borup, A., Sharifpour, M. F., Rossen, L. S., Whitehead, B., Boysen, A. T., Olesen, R., Bohn, A. B., Ridolfi, A., Brucale, M., Valle, F., Paolini, L., Radeghieri, A., Bergese, P., Miles, K., Veitch, M., Thomas, T., Ruscher, R., Wangchuk, P., Giacomin, P. ... Nejsum, P. (2025). Helminth extracellular vesicles co-opt host monocytes to drive T cell anergy. Journal of Extracellular Vesicles, 14(1), Article e70027. https://doi.org/10.1002/jev2.70027
Johansen, N. D., Modin, D., Loiacono, M. M., Harris, R. C., Dufournet, M., Larsen, C. S., Larsen, L., Wiese, L., Dalager-Pedersen, M., Claggett, B. L., Janstrup, K. H., Bartholdy, K. V., Bernholm, K. F., Borchsenius, J. I. M. H., Davidovski, F. S., Davodian, L. W., Dons, M., Duus, L. S., Espersen, C. ... Biering-Sørensen, T. (2025). High-Dose Influenza Vaccine Effectiveness against Hospitalization in Older Adults. The New England Journal of Medicine, 393(23), 2291-2302. https://doi.org/10.1056/NEJMoa2509907
Skaarup, K. G., Johansen, N. D., Modin, D., Loiacono, M. M., Harris, R. C., Dufournet, M., Larsen, C. S., Larsen, L., Wiese, L., Dalager-Pedersen, M., Claggett, B. L., Bartholdy, K. V., Bernholm, K. F., Borchsenius, J. I. M. H., Davidovski, F. S., Davodian, L. W., Dons, M., Duus, L. S., Espersen, C. ... Biering-Sørensen, T. (2025). High-Dose Versus Standard-Dose Influenza Vaccine in Heart Failure: A Prespecified Analysis of the DANFLU-2 Trial. Circulation. Heart Failure, 18(11), Article e013678. https://doi.org/10.1161/CIRCHEARTFAILURE.125.013678
Pareek, M., Johansen, N. D., Modin, D., Loiacono, M. M., Harris, R. C., Dufournet, M., Larsen, C. S., Larsen, L., Wiese, L., Dalager-Pedersen, M., Claggett, B. L., Janstrup, K. H., Bartholdy, K. V., Bernholm, K. F., Borchsenius, J. I. M. H., Davidovski, F. S., Davodian, L. W., Dons, M., Duus, L. S. ... Biering-Sørensen, T. (2025). High-dose vs. standard-dose inactivated influenza vaccine and cardiovascular outcomes in persons with or without pre-existing atherosclerotic cardiovascular disease: the DANFLU-2 trial. European Heart Journal, 46(41), 4282-4290. https://doi.org/10.1093/eurheartj/ehaf678